| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 777.8K | $53.66M | - | |
| Dir | 77.8K | $5.37M | - | |
| Dir | 43.7K | $3.01M | -1,625 | |
| Dir | 36.6K | $2.52M | - | |
| Dir | 23.7K | $1.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 10,000 | $48.39 | $483,940.00 | -6.5% | -32.3% | -27.0% | |
| Feb 9, 2023 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $51.01 | $1,530,150.00 | -1.7% | -30.2% | -28.1% | |
| Jan 19, 2023 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $51.30 | $1,539,149.00 | -1.3% | -31.5% | -33.5% | |
| Jan 17, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 10,000 | $50.46 | $504,590.17 | -3.4% | -29.4% | -29.4% | |
| Dec 15, 2022 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $58.11 | $1,743,301.60 | -1.0% | -29.8% | -31.6% | |
| Dec 13, 2022 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 10,000 | $58.67 | $586,674.55 | -3.1% | -27.2% | -28.6% | |
| Dec 6, 2022 | Posard Matthew L.46 | Director | Sell | 30,000 | $56.89 | $1,706,550.00 | -8.0% | -19.3% | -29.1% | |
| Nov 17, 2022 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $53.39 | $1,601,626.38 | -1.3% | -6.7% | -24.3% | |
| Nov 15, 2022 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sell | 5,000 | $53.81 | $269,052.55 | -37.2% | -9.1% | -27.2% | |
| Nov 15, 2022 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 10,000 | $54.13 | $541,263.11 | -2.0% | -9.1% | -27.2% |